Annual CFI
$50.72 M
+$192.39 M+135.80%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual cash flow from investing activities is currently $50.72 million, with the most recent change of +$192.39 million (+135.80%) on 31 December 2023. During the last 3 years, it has risen by +$50.73 million (+338213.33%). ACRV annual CFI is now at all-time high.ACRV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$16.01 M
+$104.06 M+118.19%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly cash flow from investing activities is currently $16.01 million, with the most recent change of +$104.06 million (+118.19%) on 30 September 2024. Over the past year, it has increased by +$14.49 million (+956.13%). ACRV quarterly CFI is now -22.03% below its all-time high of $20.54 million, reached on 31 December 2023.ACRV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$45.65 M
+$14.49 M+24.10%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock TTM cash flow from investing activities is currently -$45.65 million, with the most recent change of +$14.49 million (+24.10%) on 30 September 2024. Over the past year, it has increased by +$19.24 million (+29.65%). ACRV TTM CFI is now -190.00% below its all-time high of $50.72 million, reached on 31 December 2023.ACRV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +135.8% | +956.1% | +29.6% |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | - | - | - |
ACRV Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +135.8% | -22.0% | +116.8% | -190.0% | +67.8% |
| 5 y | 5 years | at high | +135.8% | -22.0% | +116.8% | -190.0% | +67.8% |
| alltime | all time | at high | +135.8% | -22.0% | +116.8% | -190.0% | +67.8% |
Acrivon Therapeutics Common Stock Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $16.01 M(-118.2%) | -$45.65 M(-24.1%) |
| June 2024 | - | -$88.04 M(-1605.0%) | -$60.14 M(-227.3%) |
| Mar 2024 | - | $5.85 M(-71.5%) | $47.24 M(-6.9%) |
| Dec 2023 | $50.72 M | $20.54 M(+1254.6%) | $50.72 M(-178.2%) |
| Sept 2023 | - | $1.52 M(-92.2%) | -$64.89 M(-41.8%) |
| June 2023 | - | $19.34 M(+107.3%) | -$111.52 M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $9.33 M(-109.8%) | -$131.93 M(-6.9%) |
| Dec 2022 | -$141.68 M(>+9900.0%) | -$95.07 M(+110.7%) | -$141.68 M(+204.0%) |
| Sept 2022 | - | -$45.12 M(+4101.1%) | -$46.61 M(+3030.2%) |
| June 2022 | - | -$1.07 M(+158.8%) | -$1.49 M(+258.8%) |
| Mar 2022 | - | -$415.00 K | -$415.00 K |
| Dec 2021 | -$238.00 K(+1486.7%) | - | - |
| Dec 2020 | -$15.00 K | - | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual cash flow from investing activities?
- What is the all time high annual CFI for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual CFI year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly CFI year-on-year change?
- What is Acrivon Therapeutics Common Stock TTM cash flow from investing activities?
- What is the all time high TTM CFI for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock TTM CFI year-on-year change?
What is Acrivon Therapeutics Common Stock annual cash flow from investing activities?
The current annual CFI of ACRV is $50.72 M
What is the all time high annual CFI for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual cash flow from investing activities is $50.72 M
What is Acrivon Therapeutics Common Stock annual CFI year-on-year change?
Over the past year, ACRV annual cash flow from investing activities has changed by +$192.39 M (+135.80%)
What is Acrivon Therapeutics Common Stock quarterly cash flow from investing activities?
The current quarterly CFI of ACRV is $16.01 M
What is the all time high quarterly CFI for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly cash flow from investing activities is $20.54 M
What is Acrivon Therapeutics Common Stock quarterly CFI year-on-year change?
Over the past year, ACRV quarterly cash flow from investing activities has changed by +$14.49 M (+956.13%)
What is Acrivon Therapeutics Common Stock TTM cash flow from investing activities?
The current TTM CFI of ACRV is -$45.65 M
What is the all time high TTM CFI for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high TTM cash flow from investing activities is $50.72 M
What is Acrivon Therapeutics Common Stock TTM CFI year-on-year change?
Over the past year, ACRV TTM cash flow from investing activities has changed by +$19.24 M (+29.65%)